📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Naviscan

1.1 - Company Overview

Naviscan Logo

Naviscan

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of organ-specific molecular imaging, designing, manufacturing, and distributing high-resolution PET scanners that provide unprecedented visualization of small body parts and can image virtually any body part that fits into the gantry.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Naviscan

Rain Oncology Logo

Rain Oncology

HQ: United States Website
  • Description: Provider of precision oncology therapies targeting oncogenic drivers, developing milademetan, an oral small molecule inhibitor of the p53-MDM2 complex for various cancers. Clinical programs include MANTRA (Phase 3 in dedifferentiated liposarcoma), MANTRA-2 (Phase 2 in TP53 wildtype/MDM2-amplified solid tumors), and MANTRA-4 (Phase 1/2 with atezolizumab in CDKN2A loss, TP53 wildtype tumors).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rain Oncology company profile →
Medivation Logo

Medivation

HQ: United States Website
  • Description: Provider of biopharmaceutical R&D focused on rapid development of small‑molecule drugs to treat serious diseases with limited treatment options, including the development of MDV3100 for multiple stages of advanced prostate cancer in collaboration with Astellas Pharma.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medivation company profile →
Salmedix Logo

Salmedix

HQ: United States Website
  • Description: Provider of oncology drug development focused on hematologic malignancies (blood cancers). Primary product SDX-105 is marketed by healthcare professionals in Germany for several types of blood cancers; conducts Phase II clinical trials for SDX-105 in the U.S. and Canada.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Salmedix company profile →
Nanospectra Biosciences Logo

Nanospectra Biosciences

HQ: United States Website
  • Description: Provider of particle-based therapies for thermal destruction of solid tumors, including AuroLase Therapy using AuroShell nanoparticles that absorb near-infrared light to generate heat. Offers proprietary nanoshell technology with initial clinical trials demonstrating safety and efficacy. Licenses IP to Sebacia for laser-activated acne treatment and partners with LiteCure to treat solid tumors and surface lesions in animals.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nanospectra Biosciences company profile →
Neogene Therapeutics Logo

Neogene Therapeutics

HQ: The Netherlands Website
  • Description: Provider of T cell therapies targeting cancer neo-antigens, developing technologies to engineer designer T cells with optimized neo-antigen specificities to seek and destroy cancer cells. Offers engineered TCR therapies for solid tumors, including a TP53 R175H-targeting TCR therapy currently in Phase I trials in the US.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Neogene Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Naviscan

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Naviscan

2.2 - Growth funds investing in similar companies to Naviscan

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Naviscan

4.2 - Public trading comparable groups for Naviscan

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Naviscan

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Naviscan

What does Naviscan do?

Naviscan is a provider of organ-specific molecular imaging, designing, manufacturing, and distributing high-resolution PET scanners that provide unprecedented visualization of small body parts and can image virtually any body part that fits into the gantry.

Who are Naviscan's competitors?

Naviscan's competitors and similar companies include Rain Oncology, Medivation, Salmedix, Nanospectra Biosciences, and Neogene Therapeutics.

Where is Naviscan headquartered?

Naviscan is headquartered in United States.

How many employees does Naviscan have?

Naviscan has 1,000 employees 🔒.

When was Naviscan founded?

Naviscan was founded in 2010 🔒.

What sector and industry vertical is Naviscan in?

Naviscan is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Naviscan

Who are the top strategic acquirers in Naviscan's sector and industry

Top strategic M&A buyers and acquirers in Naviscan's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Naviscan?

Top strategic M&A buyers groups and sectors for Naviscan include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Naviscan's sector and industry vertical

Which are the top PE firms investing in Naviscan's sector and industry vertical?

Top PE firms investing in Naviscan's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Naviscan's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Naviscan's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Naviscan's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Naviscan include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Naviscan's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Naviscan?

The key public trading comparables and valuation benchmarks for Naviscan include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Naviscan for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Naviscan with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Naviscan's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Naviscan with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Naviscan's' sector and industry vertical?

Access recent funding rounds and capital raises in Naviscan's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Naviscan